New octreotide pill faces off against current capsule in healthy volunteer study
Knowledge-focused
Not yet recruiting
This early-stage trial in 18 healthy adults compares a new octreotide tablet (T25) with an existing capsule (MYCAPSSA) to see how much drug gets into the blood. It also checks whether a high-fat meal changes absorption of the tablet. Participants take single doses under fasting o…
Phase: PHASE1 • Sponsor: Triastek (Shanghai) Limited • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC